Publication:
Ovarian and uterine functions in female survivors of childhood cancers

dc.contributor.coauthorKim, Samuel S.
dc.contributor.coauthorSchatmann, Glenn
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorÖktem, Özgür
dc.contributor.kuauthorSelek, Uğur
dc.contributor.kuauthorUrman, Cumhur Bülent
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:06:21Z
dc.date.issued2018
dc.description.abstractAdult survivors of childhood cancers are more prone to developing poor reproductive and obstetrical outcomes than their siblings and the general population as a result of previous exposure to chemotherapy and radiation during childhood. Chemotherapy drugs exert cytotoxic effects systemically and therefore can damage the ovaries, leading to infertility, premature ovarian failure, and, to a lesser extent, spontaneous abortions. They have very limited or no deleterious effects on the uterus that can be recognized clinically. By contrast, radiation is detrimental to both the ovaries and the uterus, thereby causing a greater magnitude of adverse effects on the female reproductive function. These include infertility, premature ovarian failure, miscarriage, fetal growth restrictions, perinatal deaths, preterm births, delivery of small-for-gestational-age infants, preeclampsia, and abnormal placentation. Regrettably, the majority of these adverse outcomes arise from radiation-induced uterine injury and are reported at higher incidence in the adult survivors of childhood cancers who were exposed to uterine radiation during childhood in the form of pelvic, spinal, or total-body irradiation. Recent findings of long-term follow-up studies evaluating reproductive performance of female survivors provided some reassurance to female cancer survivors by documenting that pregnancy and live birth rates were not significantly compromised in survivors, including those who had been treated with alkylating agents and had not received pelvic, cranial, and total-body irradiation. We aimed in this narrative review article to provide an update on the impact of chemotherapy and radiation on the ovarian and uterine function in female survivors of childhood cancer.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue2
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume23
dc.identifier.doi10.1634/theoncologist.2017-0201
dc.identifier.eissn1549-490X
dc.identifier.issn1083-7159
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85038222414
dc.identifier.urihttps://doi.org/10.1634/theoncologist.2017-0201
dc.identifier.urihttps://hdl.handle.net/20.500.14288/8965
dc.identifier.wos425135900014
dc.keywordsChildhood cancer survivors
dc.keywordsOvarian function
dc.keywordsUterine function
dc.keywordsFertility preservation
dc.keywordsPediatric cancers
dc.keywordsReproductive outcome
dc.keywordsObstetrical outcome
dc.keywordsChemotherapy
dc.keywordsRadiation
dc.language.isoeng
dc.publisherOxford University Press (OUP)
dc.relation.ispartofOncologist
dc.subjectOncology
dc.titleOvarian and uterine functions in female survivors of childhood cancers
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorÖktem, Özgür
local.contributor.kuauthorUrman, Cumhur Bülent
local.contributor.kuauthorSelek, Uğur
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files